To hear about similar clinical trials, please enter your email below
Trial Title:
Empowering Patients' Lung Cancer Screening Uptake
NCT ID:
NCT06000683
Condition:
Lung Cancer
Conditions: Official terms:
Lung Neoplasms
Study type:
Interventional
Study phase:
N/A
Overall status:
Active, not recruiting
Study design:
Allocation:
N/A
Intervention model:
Single Group Assignment
Primary purpose:
Screening
Masking:
None (Open Label)
Intervention:
Intervention type:
Behavioral
Intervention name:
Patient education
Description:
Patients will be sent information (in preferred language) on lung cancer risk, lung
cancer screening (LCS) benefits, harms, false positive rates, recommendations of
follow-up for positive results, and exam insurance coverage.
Arm group label:
Empower LCS
Intervention type:
Behavioral
Intervention name:
Referral to financial navigation resources
Description:
Patients who self-report needing help with health-related social risks at baseline will
be sent a brochure (in preferred language) from patient advocate foundation (PAF), a
national non-profit financial navigation organization, where patients can self-refer.
Arm group label:
Empower LCS
Intervention type:
Behavioral
Intervention name:
Patient Reminders
Description:
Within 2 weeks prior to primary care appointment, patients will receive a text message or
a phone call (if not having a phone that receives text messaging) encouraging patients to
discuss the LCS with their provider.
Arm group label:
Empower LCS
Intervention type:
Behavioral
Intervention name:
Provider Reminers
Description:
Within 2 weeks prior to primary care appointment, providers will be notified of their
patient's eligibility for LCS.
Arm group label:
Empower LCS
Summary:
Lung cancer is the leading cause of cancer related mortality. Lung cancer screening (LCS)
with low dose computed tomography (LDCT) decreases mortality rate of lung cancer by 20%.
Yet many patients who are eligible for lung cancer screening are still falling through
the cracks which prevents patients the ability to detect lung cancer early. This study
will test the effect of a a multi-level intervention on ordering LDCT within 6 months
after patient enrollment. Our proposed intervention includes (1) Primary care provider
notifications of patients' LCS eligibility; (2) patients' education ; (3) patients'
referral to financial navigation resources; and (4) patients' reminder to discuss LCS
during PCP visit.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
1. Aged 50- 80 years of age.
2. Be able to Speak English, Spanish, or Vietnamese
3. Must have a scheduled appointment with their Primary Care Providers within next one
to three months.
4. The Scheduled PCP appointment is at any of the UCI Health primary care clinics in
Orange County including two UCI federally qualified health centers
5. History of 20 pack year smoking history ( based on survey self report)
6. Current smoker or a former smoker who has quit smoking within the last 15 years
(based on survey self report)
Exclusion Criteria:
1. Prior history of lung cancer
2. chest CT for any reason in the last 12 months based on self-report and UCI EMR
3. history of Alzheimer's disease or dementia
Gender:
All
Minimum age:
50 Years
Maximum age:
80 Years
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
UCI Health - Costa Mesa
Address:
City:
Costa Mesa
Zip:
92627
Country:
United States
Facility:
Name:
UCI Health Gottschalk Medical Plaza
Address:
City:
Irvine
Zip:
92697
Country:
United States
Facility:
Name:
UCI Health - Laguna Hills
Address:
City:
Laguna Hills
Zip:
92653
Country:
United States
Facility:
Name:
UCI Health - Newport Beach MacArthur
Address:
City:
Newport Beach
Zip:
92660
Country:
United States
Facility:
Name:
UCI Medical Center
Address:
City:
Orange
Zip:
92868
Country:
United States
Facility:
Name:
UCI Health - Tustin
Address:
City:
Tustin
Zip:
92670
Country:
United States
Facility:
Name:
UCI Health-Yorba Linda
Address:
City:
Yorba Linda
Zip:
92886
Country:
United States
Start date:
October 13, 2023
Completion date:
December 2025
Lead sponsor:
Agency:
University of California, Irvine
Agency class:
Other
Source:
University of California, Irvine
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06000683
